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As a response against serious infection, there is often a need to produce more leukocytes to defend the
organism against the infectious agent. In this issue of Cell Stem Cell, Goodell and colleagues (Feng et al.,
2008) find a link between regulators of host defense and hematopoietic stem cells.Even though hematopoietic stem cells
(HSCs) in steady state are predominantly
inactive and quiescent, they possess an
enormous potential to proliferate and
expand. Although bone marrow (BM)
transplantation protocols have taken ad-
vantage of this proliferative capacity for
decades, little is known about the use
for this potential during more physiologi-
cal conditions of hematopoietic stress.
However, recent studies have demon-
strated that increased proliferation and al-
tered hematopoietic differentiation can be
induced as part of the immune response
to infectious disease (Nagai et al., 2006).
Intriguingly, the discovery of Toll-like re-
ceptor expression in HSCs suggests that
this activation, which probably serves to
replenish the effector cells, seems to be
a direct early event in the innate host
defense (Nagai et al., 2006). In this issue
of Cell Stem Cell, Feng et al. (2008) sup-
port these findings and provide a genetic
link between immune system signaling
and in vivo function of HSCs.
Thep47GTPases, also referred toas im-
munity-related GTPases, have been char-
acterized as interferon-responsive effec-
tors of the immune system. One of these
GTPases, Lrg-47, is required for host
defense against many intracellular patho-
gens, demonstrated by impaired intracel-
lular microbial killing ability by Lrg-47/
mice (MacMicking et al., 2003). Upon in-
fection with several pathogens, Lrg-47/
mice fail to control the infection and de-
velop pancytopenia prior to death (Feng
et al., 2004). Recently, Venezia et al.
(2004) studied gene expression profiles in
proliferating and quiescent HSCs and
identified Lrg-47 as a potential HSC regu-
latory gene (Venezia et al., 2004). Because
Lrg-47 was upregulated in HSCs afterhematopoietic stress and profound hema-
topoietic defects have been observed af-
ter infectious challenge in Lrg-47/ mice,
Feng et al. (2008) hypothesized that Lrg-
47 might be an HSC regulator after distur-
bance of hematopoietic homeostasis.
In their present paper, they indeed
report delayed hematopoietic recovery
after 5-fluorouracil (5FU) myeloablation
of Lrg-47/ mice, supporting earlier ob-
servations describing an upregulation of
Lrg-47 1 day after this treatment (Venezia
et al., 2004). Because this chemothera-
peutic agent selectively kills dividing cells,
causing an activation response of the qui-
escent HSCs to replenish the hematopoi-
etic system, these findings indicate that
theproliferative response to hemaopoietic
stress by Lrg-47/ HSCs is impaired. A
profound repopulation defect was also
detected in Lrg-47/ HSCs because a
robust engraftment was not seen when a
25-fold excess of knockout BM cells was
used to compete with normal control mar-
row in a competitive repopulation exper-
iment. The percentage of Lin-Sca1+
c-kit+ progenitor and stem cells was sim-
ilar in Lrg-47/ and normal HSCs, so
the repopulation deficiency is mostly
a functional deficiency and cannot be
explained by a reduction of HSCs.
Additionally, data are presented indicating
that Lrg-47 may regulate apoptotic path-
ways, because 5FU-treated Lrg-47-defi-
cient HSCs exhibited increased apo-
ptosis. Thus, it seems like Lrg-47 has
a critical role in boosting HSC proliferation
and protecting the HSC pool when the he-
matopoietic system needs to be replen-
ished. Intriguingly, these effects proved
absolutely critical for normal immune
function. After infection with M. Avium,
there was no expansion of Lrg-47/ Lin-Cell StemSca1+c-kit+ progenitor and stem cells,
whereas this population in wild-type (WT)
mice was amplified 15-fold. Similarly,
there was a substantial reduction of func-
tional CFCs after infection compared to
WT animals. The results are logical in
one sense. A gene that regulates success-
ful response to infection may also be in-
volved in regulating production of more
leukocytes by stimulating a reaction at
the HSC level of the hematopoietic hier-
archy to produce more white cells for ac-
tive defense against microorganisms.
However, the presented data are also
somewhat paradoxical. Contrary to the
delay in proliferative response and im-
paired reconstitution capacity observed
after hematopoietic stress, steady-state
Lrg-47/ HSCs are hyperproliferative, as
measured by BrdU incorporation of di-
viding cells. Accordingly, there was a sub-
stantially increased loss of HSC-enriched
side population cells upon 5FU treatment
of Lrg-47/ mice. Based on these data,
the authors present a hypothesis that
Lrg-47 may be a regulator that keeps
HSCs quiescent. Thus, the findings by
Feng et al. (2008) suggest that Lrg-47
has multiple roles in governing HSC fate.
In steady state, it protects the HSCs by
maintaining quiescence. During situations
of hematopoietic stress, Lrg-47 instead
boosts proliferation as well as restrains
cell death, resulting in an expansion of
HSCs when the hematopoietic system is
in need of replenishment. Additionally,
the study implicates Lrg-47 as a genetic
link between the immune system and
HSCs and demonstrates that an expan-
sion of hematopoietic progenitor and
stem cells is an early, thus possibly direct,
event in the immune response to infec-
tious disease.Cell 2, January 2008 ª2008 Elsevier Inc. 1
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In this issue of Cell Stem Cell, Feng et al. (2008) present a study implicating the interferon-inducible
GTPase Lrg-47 as a multifunctional link between the immune response to infectious disease and HSC
function. The authors present data demonstrating that Lrg-47 is critical for maintaining HSC quiescence
in steady-state conditions (depicted in blue). In contrast, during situations of bacterial infection or chem-
ically induced hematopoietic stress, HSCs undergo an Lrg-47-dependent expansion to replenish the
hematopoietic system (red). Because Lrg-47 has been associated with the cytoskeleton and cell migration,
it is conceivable that the multifunctional roles of Lrg-47 are mediated through migration within the HSC
niche and lodging to different microenvironments depending on physiological state (dashed green line).So how can a molecule that is impor-
tant for maintaining HSC quiescence be
critical for HSC expansion after hemato-
poietic stress at the same time? On the
molecular level, it is not known how Lrg-
47 acts to regulate HSCs and it will be of
great interest to follow future studies re-2 Cell Stem Cell 2, January 2008 ª2008 Elsegarding the mechanisms behind its multi-
ple roles in HSC function. However, the
hyperproliferation of hematopoietic pro-
genitors observed in Lrg-47 mice could
possibly lead to an exhaustion of the
HSC pool and impaired reconstitution
capacity. This could be linked with earliervier Inc.findings demonstrating that Lrg-47 may
regulate cytoskeletal changes or cell
motility (Kaiser et al., 2004). This hypothe-
sis fits well with the growing evidence
implicating the physical location of HSCs
within the endosteal stem cell niche to
play a strong role in regulating the prolifer-
ation of HSCs (Wilson and Trumpp, 2006)
(Figure 1). It may therefore be possible
that Lrg-47 does not directly regulate qui-
escence or proliferation but is rather in-
volved in HSC lodging to and migration
from the stemcell niche and thereby affect
the stem cell properties or ‘‘stemness’’ of
HSCs.
Nevertheless, the intriguing work by
Feng et al. (2008) will undoubtedly in-
crease the interest for the connection
between HSC function and the immune
response to infectious disease.
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